查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1922459

日本荷尔蒙补充疗法市场报告：按产品、给药途径、疾病类型和地区划分（2026-2034年）

Japan Hormone Replacement Therapy Market Report by Product, Route of Administration, Type of Disease, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 116 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2025年，日本荷尔蒙补充疗法市场规模达6.052亿美元。展望未来，IMARC集团预测，到2034年，该市场规模将达到10.698亿美元，2026年至2034年的复合年增长率（CAGR）为6.53%。推动该行业发展的关键因素包括：激素紊乱症发病率的上升、技术的显着进步、给药技术的持续创新以及政府的支持计划和报销政策。

荷尔蒙补充疗法（HRT）是一种用于解决个别荷尔蒙失衡问题的医疗保健方法。该治疗方法透过服用外源性荷尔蒙来补充或取代人体自身产生的荷尔蒙。医疗保健提供者（通常是内分泌科医生或妇科医生）会在对患者的病历和症状进行全面评估后，开立HRT处方。 HRT的目标是透过持续补充控制剂量的荷尔蒙来缓解与荷尔蒙缺乏或波动相关的症状。在治疗期间，医生会密切监测荷尔蒙水平，以确保其维持在理想范围内，从而促进整体健康并减少荷尔蒙失衡带来的负面影响。

日本荷尔蒙补充疗法市场的发展趋势：

由于多种因素与全球医疗保健趋势相符，日本的荷尔蒙补充疗法市场正经历显着成长。其中一个关键驱动因素是荷尔蒙失衡及相关疾病的日益增多。由于久坐不动的生活方式、压力和老龄化等因素，这些疾病在人群中的发病率不断上升。这些因素导致人们对荷尔蒙补充疗法等治疗性介入的需求日益增长。此外，患者和医疗专业人员对荷尔蒙替代疗法作为一种有效治疗选择的认知度和接受度不断提高，也促进了市场扩张。这种认知度的提升正在推动日本市场的发展。日本人口老化也是一个重要的驱动因素。随着老龄化，荷尔蒙失衡的发生率越来越高，老年人对荷尔蒙替代疗法的需求也不断增加。此外，荷尔蒙输送方式（例如经皮吸收贴片和植入式装置）的持续技术进步，使得荷尔蒙替代疗法的给药更加便捷和精准。这提高了患者的依从性，改善了治疗效果，从而进一步推动了市场成长。此外，政府为帮助患者以可负担的价格获得激素替代疗法而推出的各项倡议以及优惠的报销政策，也为市场扩张创造了有利环境。这些因素综合起来表明，在预测期内，日本荷尔蒙补充疗法市场在解决荷尔蒙失衡及相关健康问题方面的重要性和潜力将会增加。

本报告解答的关键问题

  • 日本荷尔蒙补充疗法市场目前发展状况如何？您认为未来几年该市场会如何发展？
  • 新冠疫情对日本荷尔蒙补充疗法市场产生了哪些影响？
  • 日本荷尔蒙补充疗法市场的产品组成是什么？
  • 日本荷尔蒙补充疗法市场按给药途径分類的情况如何？
  • 日本荷尔蒙补充疗法市场按疾病类型分類的组成是怎样的？
  • 请介绍日本荷尔蒙补充疗法市场价值链的各个环节。
  • 日本荷尔蒙补充疗法的主要驱动因素和挑战是什么？
  • 日本荷尔蒙补充疗法市场的结构是怎么样的？主要参与者有哪些？
  • 日本荷尔蒙补充疗法市场竞争程度如何？

目录

第一章：序言

第二章：调查范围与调查方法

  • 调查目标
  • 相关利益者
  • 数据来源
  • 市场估值
  • 调查方法

第三章执行摘要

第四章：日本荷尔蒙补充疗法市场－简介

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争资讯

第五章 日本荷尔蒙补充疗法市场概览

  • 过去和当前的市场趋势（2020-2025）
  • 市场预测（2026-2034）

第六章 日本荷尔蒙补充疗法市场－依产品细分

  • 雌激素替代疗法
  • 人体生长荷尔蒙替代疗法
  • 甲状腺替代疗法
  • 睾酮替代疗法
  • 其他的

第七章：日本荷尔蒙补充疗法市场－依给药途径细分

  • 口服
  • 注射
  • 经皮

第八章：日本荷尔蒙补充疗法市场－依疾病类型细分

  • 更年期症状
  • 甲状腺机能低下症
  • 男性性腺功能低下症
  • 生长激素缺乏症
  • 其他的

第九章：日本荷尔蒙补充疗法市场：按地区划分

  • 关东地区
  • 关西、近畿地区
  • 中部地区
  • 九州和冲绳地区
  • 东北部地区
  • 中国地区
  • 北海道地区
  • 四国地区

第十章：日本荷尔蒙补充疗法市场的竞争格局

  • 概述
  • 市场结构
  • 市场公司定位
  • 关键成功策略
  • 竞争对手仪錶板
  • 企业估值象限

第十一章主要企业概况

第十二章：日本荷尔蒙补充疗法市场：产业分析

  • 驱动因素、限制因素和机会
  • 波特五力分析
  • 价值链分析

第十三章附录

简介目录
Product Code: SR112026A19204

Japan hormone replacement therapy market size reached USD 605.2 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,069.8 Million by 2034, exhibiting a growth rate (CAGR) of 6.53% during 2026-2034. The industry is experiencing growth due to several key drivers, including the increasing incidence of hormonal disorders, notable technological advancements, continuous innovations in delivery techniques, and supportive government programs and reimbursement policies.

Access the full market insights report Request Sample

Hormone replacement therapy (HRT) is a medical approach employed to address hormonal imbalances in individuals. This treatment involves the administration of external hormones to supplement or substitute the natural hormones produced by the body. Typically, healthcare providers, such as endocrinologists or gynecologists, prescribe HRT after a comprehensive assessment of the patient's medical history and symptoms. HRT's objective is to alleviate symptoms related to hormonal deficiencies or variations by consistently delivering controlled hormone doses. The treatment undergoes careful monitoring to ensure that hormone levels remain within the desired range, promoting overall well-being and potentially mitigating the negative effects of hormonal imbalances.

JAPAN HORMONE REPLACEMENT THERAPY MARKET TRENDS:

The Japan hormone replacement therapy market is experiencing substantial growth, driven by a combination of factors that align with global healthcare trends. A key driver is the increasing prevalence of hormonal imbalances and related disorders, which are becoming more prevalent in the population due to factors like sedentary lifestyles, stress, and the natural process of aging. These factors have created a growing need for therapeutic interventions such as hormone replacement therapy. Furthermore, the market benefits from the rising awareness and acceptance of HRT as an effective treatment option among both patients and healthcare professionals. This increasing recognition has contributed to the expansion of the market in Japan. The aging demographic in Japan is another significant driver, as hormonal imbalances become more common with age. This demographic shift has led to a higher demand for HRT among the elderly population. Moreover, ongoing technological advancements in hormone delivery methods, such as transdermal patches and implantable devices, are making HRT more convenient and targeted in its administration. This enhances patient compliance and improves treatment outcomes, further fueling market growth. Additionally, supportive government initiatives and favorable reimbursement policies aimed at ensuring affordable access to HRT for patients are creating favorable conditions for market expansion. These collective factors will underscore the growing importance and potential of the Japan hormone replacement therapy market in addressing hormonal imbalances and related health concerns over the forecasted period.

JAPAN HORMONE REPLACEMENT THERAPY MARKET SEGMENTATION:

Product Insights:

  • To get detailed segment analysis of this market Request Sample
  • Estrogen Replacement Therapy
  • Human Growth Hormone Replacement Therapy
  • Thyroid Replacement Therapy
  • Testosterone Replacement Therapy
  • Others
  • Estrogen Replacement Therapy
  • Human Growth Hormone Replacement Therapy
  • Thyroid Replacement Therapy
  • Testosterone Replacement Therapy
  • Others

Route of Administration Insights:

  • Oral
  • Parenteral
  • Transdermal
  • Oral
  • Parenteral
  • Transdermal

Type of Disease Insights:

  • Menopause
  • Hypothyroidism
  • Male Hypogonadism
  • Growth Hormone Deficiency
  • Others
  • Menopause
  • Hypothyroidism
  • Male Hypogonadism
  • Growth Hormone Deficiency
  • Others

Regional Insights:

  • To get detailed regional analysis of this market Request Sample
  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

  • KEY QUESTIONS ANSWERED IN THIS REPORT
  • How has the Japan hormone replacement therapy market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan hormone replacement therapy market?
  • What is the breakup of the Japan hormone replacement therapy market on the basis of product?
  • What is the breakup of the Japan hormone replacement therapy market on the basis of route of administration?
  • What is the breakup of the Japan hormone replacement therapy market on the basis of type of disease?
  • What are the various stages in the value chain of the Japan hormone replacement therapy market?
  • What are the key driving factors and challenges in the Japan hormone replacement therapy?
  • What is the structure of the Japan hormone replacement therapy market and who are the key players?
  • What is the degree of competition in the Japan hormone replacement therapy market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Hormone Replacement Therapy Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Hormone Replacement Therapy Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Hormone Replacement Therapy Market - Breakup by Product

  • 6.1 Estrogen Replacement Therapy
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Forecast (2026-2034)
  • 6.2 Human Growth Hormone Replacement Therapy
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Forecast (2026-2034)
  • 6.3 Thyroid Replacement Therapy
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2020-2025)
    • 6.3.3 Market Forecast (2026-2034)
  • 6.4 Testosterone Replacement Therapy
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2020-2025)
    • 6.4.3 Market Forecast (2026-2034)
  • 6.5 Others
    • 6.5.1 Historical and Current Market Trends (2020-2025)
    • 6.5.2 Market Forecast (2026-2034)

7 Japan Hormone Replacement Therapy Market - Breakup by Route of Administration

  • 7.1 Oral
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Forecast (2026-2034)
  • 7.2 Parenteral
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Forecast (2026-2034)
  • 7.3 Transdermal
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2020-2025)
    • 7.3.3 Market Forecast (2026-2034)

8 Japan Hormone Replacement Therapy Market - Breakup by Type of Disease

  • 8.1 Menopause
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Forecast (2026-2034)
  • 8.2 Hypothyroidism
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Forecast (2026-2034)
  • 8.3 Male Hypogonadism
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2020-2025)
    • 8.3.3 Market Forecast (2026-2034)
  • 8.4 Growth Hormone Deficiency
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2020-2025)
    • 8.4.3 Market Forecast (2026-2034)
  • 8.5 Others
    • 8.5.1 Historical and Current Market Trends (2020-2025)
    • 8.5.2 Market Forecast (2026-2034)

9 Japan Hormone Replacement Therapy Market - Breakup by Region

  • 9.1 Kanto Region
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2020-2025)
    • 9.1.3 Market Breakup by Product
    • 9.1.4 Market Breakup by Route of Administration
    • 9.1.5 Market Breakup by Type of Disease
    • 9.1.6 Key Players
    • 9.1.7 Market Forecast (2026-2034)
  • 9.2 Kansai/Kinki Region
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2020-2025)
    • 9.2.3 Market Breakup by Product
    • 9.2.4 Market Breakup by Route of Administration
    • 9.2.5 Market Breakup by Type of Disease
    • 9.2.6 Key Players
    • 9.2.7 Market Forecast (2026-2034)
  • 9.3 Central/ Chubu Region
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2020-2025)
    • 9.3.3 Market Breakup by Product
    • 9.3.4 Market Breakup by Route of Administration
    • 9.3.5 Market Breakup by Type of Disease
    • 9.3.6 Key Players
    • 9.3.7 Market Forecast (2026-2034)
  • 9.4 Kyushu-Okinawa Region
    • 9.4.1 Overview
    • 9.4.2 Historical and Current Market Trends (2020-2025)
    • 9.4.3 Market Breakup by Product
    • 9.4.4 Market Breakup by Route of Administration
    • 9.4.5 Market Breakup by Type of Disease
    • 9.4.6 Key Players
    • 9.4.7 Market Forecast (2026-2034)
  • 9.5 Tohoku Region
    • 9.5.1 Overview
    • 9.5.2 Historical and Current Market Trends (2020-2025)
    • 9.5.3 Market Breakup by Product
    • 9.5.4 Market Breakup by Route of Administration
    • 9.5.5 Market Breakup by Type of Disease
    • 9.5.6 Key Players
    • 9.5.7 Market Forecast (2026-2034)
  • 9.6 Chugoku Region
    • 9.6.1 Overview
    • 9.6.2 Historical and Current Market Trends (2020-2025)
    • 9.6.3 Market Breakup by Product
    • 9.6.4 Market Breakup by Route of Administration
    • 9.6.5 Market Breakup by Type of Disease
    • 9.6.6 Key Players
    • 9.6.7 Market Forecast (2026-2034)
  • 9.7 Hokkaido Region
    • 9.7.1 Overview
    • 9.7.2 Historical and Current Market Trends (2020-2025)
    • 9.7.3 Market Breakup by Product
    • 9.7.4 Market Breakup by Route of Administration
    • 9.7.5 Market Breakup by Type of Disease
    • 9.7.6 Key Players
    • 9.7.7 Market Forecast (2026-2034)
  • 9.8 Shikoku Region
    • 9.8.1 Overview
    • 9.8.2 Historical and Current Market Trends (2020-2025)
    • 9.8.3 Market Breakup by Product
    • 9.8.4 Market Breakup by Route of Administration
    • 9.8.5 Market Breakup by Type of Disease
    • 9.8.6 Key Players
    • 9.8.7 Market Forecast (2026-2034)

10 Japan Hormone Replacement Therapy Market - Competitive Landscape

  • 10.1 Overview
  • 10.2 Market Structure
  • 10.3 Market Player Positioning
  • 10.4 Top Winning Strategies
  • 10.5 Competitive Dashboard
  • 10.6 Company Evaluation Quadrant

11 Profiles of Key Players

  • 11.1 Company A
    • 11.1.1 Business Overview
    • 11.1.2 Product Portfolio
    • 11.1.3 Business Strategies
    • 11.1.4 SWOT Analysis
    • 11.1.5 Major News and Events
  • 11.2 Company B
    • 11.2.1 Business Overview
    • 11.2.2 Product Portfolio
    • 11.2.3 Business Strategies
    • 11.2.4 SWOT Analysis
    • 11.2.5 Major News and Events
  • 11.3 Company C
    • 11.3.1 Business Overview
    • 11.3.2 Product Portfolio
    • 11.3.3 Business Strategies
    • 11.3.4 SWOT Analysis
    • 11.3.5 Major News and Events
  • 11.4 Company D
    • 11.4.1 Business Overview
    • 11.4.2 Product Portfolio
    • 11.4.3 Business Strategies
    • 11.4.4 SWOT Analysis
    • 11.4.5 Major News and Events
  • 11.5 Company E
    • 11.5.1 Business Overview
    • 11.5.2 Product Portfolio
    • 11.5.3 Business Strategies
    • 11.5.4 SWOT Analysis
    • 11.5.5 Major News and Events

12 Japan Hormone Replacement Therapy Market - Industry Analysis

  • 12.1 Drivers, Restraints, and Opportunities
    • 12.1.1 Overview
    • 12.1.2 Drivers
    • 12.1.3 Restraints
    • 12.1.4 Opportunities
  • 12.2 Porters Five Forces Analysis
    • 12.2.1 Overview
    • 12.2.2 Bargaining Power of Buyers
    • 12.2.3 Bargaining Power of Suppliers
    • 12.2.4 Degree of Competition
    • 12.2.5 Threat of New Entrants
    • 12.2.6 Threat of Substitutes
  • 12.3 Value Chain Analysis

13 Appendix